Warner R L, Bless N M, Lewis C S, Younkin E, Beltran L, Guo R, Johnson K J, Varani J
Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Free Radic Biol Med. 2000 Jul 1;29(1):8-16. doi: 10.1016/s0891-5849(00)00282-3.
Rats were subjected to acute lung injury by the intra-alveolar formation of IgG immune complexes of bovine serum albumin (BSA) and anti-BSA. In this model of injury, complement activation occurs and large numbers of neutrophils invade the interstitium and alveolar space. In the present study, animals were treated with intratracheal catalase concomitantly with anti-BSA or after a lag period of 5-120 min. Catalase treatment at time-zero or at 5 min post injury failed to prevent lung injury as indicated by permeability change, histological features, and neutrophil influx. However, treatment after a delay of 15-30 min (but not 120 min) afforded substantial protection. Consistent with past findings [19], lung injury was accompanied by an accumulation of matrix metalloproteinase 9 (MMP-9) in bronchoalveolar lavage (BAL) fluid. There was a strong correlation between inhibition of injury and reduction in MMP-9 levels. In vitro studies conducted in parallel revealed that unstimulated alveolar macrophages did not produce measurable MMP-9, while there was a large induction following exposure to the same immune complexes that initiated injury in vivo. MMP-2 was also slightly upregulated under the same conditions. Concomitant treatment with catalase greatly inhibited MMP-9 production by macrophages in response to immune complexes, but this treatment had little effect on basal production of either MMP-9 or MMP-2 by macrophage. The same concentration of catalase that suppressed MMP-9 elaboration also inhibited the production of tumor necrosis factor alpha. In contrast, when neutrophils were treated with catalase and then exposed to immune complexes, the antioxidant failed to prevent the release of either MMP-2 or MMP-9. Taken together, these findings demonstrate that antioxidant treatment interferes with elaboration of MMPs by alveolar macrophages. Protection against lung injury is correlated with reduction in MMP levels in the BAL fluid.
通过在肺泡内形成牛血清白蛋白(BSA)和抗BSA的IgG免疫复合物,使大鼠遭受急性肺损伤。在这种损伤模型中,补体被激活,大量中性粒细胞侵入间质和肺泡腔。在本研究中,动物在给予抗BSA的同时或在5 - 120分钟的延迟期后接受气管内过氧化氢酶治疗。损伤后即刻或5分钟时给予过氧化氢酶治疗未能预防肺损伤,这可通过通透性变化、组织学特征和中性粒细胞浸润来表明。然而,延迟15 - 30分钟(但不是120分钟)后进行治疗可提供显著的保护作用。与过去的研究结果[19]一致,肺损伤伴随着支气管肺泡灌洗(BAL)液中基质金属蛋白酶9(MMP - 9)的积累。损伤的抑制与MMP - 9水平的降低之间存在很强的相关性。同时进行的体外研究表明,未受刺激的肺泡巨噬细胞不产生可测量的MMP - 9,而在暴露于与体内引发损伤相同的免疫复合物后会有大量诱导产生。在相同条件下,MMP - 2也略有上调。过氧化氢酶与免疫复合物同时治疗可极大地抑制巨噬细胞产生MMP - 9,但这种治疗对巨噬细胞基础产生的MMP - 9或MMP - 2影响很小。抑制MMP - 9生成的相同浓度的过氧化氢酶也抑制肿瘤坏死因子α的产生。相反,当中性粒细胞用过氧化氢酶处理后再暴露于免疫复合物时,这种抗氧化剂未能阻止MMP - 2或MMP - 9的释放。综上所述,这些发现表明抗氧化剂治疗会干扰肺泡巨噬细胞对基质金属蛋白酶的生成。对肺损伤的保护作用与BAL液中MMP水平的降低相关。